Trials / Completed
CompletedNCT02697149
Nonradiation-to-endoscopist Endoscopic Retrograde Cholangiopancreatography in Patients With Complexity Level I/II
The Effectiveness and Safety of Nonradiation-to-endoscopist Endoscopic Retrograde Cholangiopancreatography in Patients With Complexity Level I/II
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 219 (actual)
- Sponsor
- Air Force Military Medical University, China · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Accepted
Summary
Radiation exposure may put endoscopists at risk when performing endoscopic retrograde cholangiopancreatography. Although non-radiation endoscopic retrograde cholangiopancreatography was reported in pregnant women in previous reports, it remains unclear whether endoscopic retrograde cholangiopancreatography is also effective and safe when endoscopists were not expose to radiation. This study was to evaluate the effectiveness and safety of nonradiation-to-endoscopist endoscopic retrograde cholangiopancreatography in patients with complexity level I/II.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | nonradiation-to-endoscopist endoscopic retrograde cholangiopancreatography | All patients received magnetic resonance cholangiopancreatography before the procedure. Characteristics of lesions (e.g. common bile duct stones, stenosis) in detail was identified. During the procedure, the endoscopist was not exposed to radiation. If fluoroscopy was needed, after contrast injection (sometimes not necessary), the endoscopist went outside of the operation room and observed the X-ray image by remote control of the fluoroscopy machine. |
| RADIATION | standard endoscopic retrograde cholangiopancreatography | Patients received standard endoscopic retrograde cholangiopancreatography. Fluoroscopy was normally used when necessary. |
Timeline
- Start date
- 2015-12-01
- Primary completion
- 2016-04-01
- Completion
- 2016-04-01
- First posted
- 2016-03-03
- Last updated
- 2016-07-21
Locations
2 sites across 1 country: China
Source: ClinicalTrials.gov record NCT02697149. Inclusion in this directory is not an endorsement.